† This study compared blind intubation using two supraglottic airway devices (SADs) in patients with anticipated difficult airways. † Intubation was successful at the first attempt in 69% of patients using the sILMA TM tube through the sILMA TM . † Success rate using a Magill PVC tube through the i-gel TM was very low (15%). † The difference between SADs was related to the SAD rather than the type of tracheal tube used.
Background. The single-use supraglottic airway device i-gel TM has been described in several case reports as a conduit for intubation, but no prospective data about success rates of blind intubation are available. Therefore, we performed this prospective randomized controlled trial to compare the success rate of blind tracheal intubation with a Magill PVC tube through the i-gel TM with intubation using an sILMA TM PVC tube through the singleuse intubating laryngeal mask airway (sILMA TM ).
Methods. With ethics committee approval and written informed consent, 80 patients with predictors of a difficult airway were computer randomized to either supraglottic airway device (SAD). The corresponding tracheal tube (TT) was introduced through the SAD under fibreoptic visualization but without fibreoptic guidance. Primary outcome was blind intubation success rate. Times, airway leak pressure, fibreoptic view, and adverse events were recorded. To control for the influence of the TT, we compared data from 40 patients described in an accompanying study (sILMA TM with Magill TT and i-gel TM with sILMA TM TT).
Results. Blind intubation success rate through the sILMA TM (69%) was higher than with the i-gel TM (15%, P,0.001). Data from the other patient group excluded the TT type as the primary cause for the difference in success rate. Removal of SADs was without problems with no difference between the type of SAD.
Conclusions. Blind tracheal intubation using the sILMA TM tube through the sILMA TM is much more successful than blind intubation with a Magill PVC tube through the i-gel TM . Because of its low success rate, we would not recommend blind intubation through the i-gel TM .
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The i-gel TM (Intersurgical Ltd, Wokingham, Berkshire, UK, Figs 1B and 2) is a supraglottic airway device (SAD) that is made of a thermoplastic elastomer (SEBS, styrene ethylene butadiene styrene) 1 and does not need an inflatable cuff to provide the airway seal. The advantages are easy insertion and possibly less tissue compression. Its easy placement and sufficient seal pressure for clinical use has been well documented. 2 -6 The large airway diameter of the i-gel TM enables the introduction of a tracheal tube (TT) through the i-gel TM . 7 As fibreoptic bronchoscopes are not ubiquitously Fig. 1A ). The ILMA TM is a widely accepted and clinically investigated device to facilitate intubation. 10 11 The first-attempt success rate for blind tracheal intubation through the ILMA TM is 80 -87% 11 12 and is improved with the use of a fibrescope to 93%.
12
Until now, there were only case reports, a study on manikins, 13 and one limited controlled trial evaluating the clinical performance of blind intubation through the i-gel TM .
14 Therefore, we performed this prospective randomized controlled trial to evaluate the success rates of blind tracheal intubation using a Magill PVC tube through the i-gel TM with intubation using an sILMA TM PVC tube through the single-use intubating laryngeal mask airway (sILMA TM ). Patients were randomly assigned to two groups (computer-generated randomization: www.randomization .com) using sealed, opaque envelopes: Group 1, placement of an i-gel TM and Magill PVC tube; and Group 2, placement of an sILMA TM and sILMA TM tube. Twenty-four staff anaesthetists with experience in the use of both SADs and skilled in fibreoptic-guided tracheal intubation through SADs participated in this investigation. All participants were under supervision by one of the main study authors.
Premedication was with oral midazolam 7.5 mg 30 min before induction of anaesthesia. Patients were asked to remove dentures or a dental plate before anaesthesia. A doughnut-shaped pillow was used to achieve optimal position. Patients were monitored according to our standard clinical operating procedures following the American Society of Anesthesiologists' recommendations.
Anaesthesia was induced using propofol 2% and fentanyl 2-3 mg kg -1 , and maintained with i.v. propofol to keep BIS 40-60. No neuromuscular blocking drugs were given before SAD insertion, which reflects the clinical practice of placing SADs at our institution. After the insertion of the SAD and completing all measurements, neuromuscular blocking drugs were administered to decrease the incidence of coughing during blind intubation and to reduce complications during SAD removal. 17 After loss of eye lash reflex, monitored, sufficient bag-mask ventilation was performed (to maintain Sp O 2 .96% and normal capnography reading) and the lubricated i-gel TM or sILMA TM was introduced according to randomization. Germany, or Rü sch GmbH, Kernen, Germany). An initial assessment of ventilation was made by gently squeezing the reservoir bag and observing end-tidal carbon dioxide waveforms and chest movements. 20 In the case of adequate ventilation, leak pressure was measured as described below. Adequate ventilation was defined as two consecutive tidal volumes of at least 6 ml kg 21 ideal body weight (height in cm2100 in kg) during pressure-controlled ventilation at 17 cm H 2 O applied by the anaesthetic machine. 21 22 When ventilation was not adequate, up to three minor airway interventions could be performed (i.e. adjusting head/neck position, changing depth of insertion). 23 If the first SAD failed after three attempts, the other SAD was used, again allowing three manoeuvres. 21 Time necessary for insertion was measured from the time the face mask was taken away from the face until the appearance of the CO 2 trace on the capnograph.
Insertion of the SAD

Intubation
A fibrescope was primed with either a slightly curved lubricated size 7.0 mm Magill PVC TT (Rü sch TM Super Safety Clear, Group 1, i-gel TM ) or a lubricated reinforced 7.0 mm sILMA TM TT (Group 2, sILMA TM ) according to randomization. After effective neuromuscular block was confirmed by loss of twitch response, and after 2 min of oxygenation, the breathing system was disconnected and the tube with the fibrescope was introduced. The best fibreoptic view from the outlet of the SAD on the glottis was graded from 1 to 4 (1, vocal cords entirely visible; 2, vocal cords or arytenoid cartilages partially visible; 3, epiglottis only visible; 4, no laryngeal structures visible). 20 If possible, the TT was advanced through the glottic opening under continuous visualization. Because the tip of the fibrescope was proximal to the tip of the tube (Fig. 2) , there was no fibreoptic guidance possible, but advancement of the tube could be stopped without applying force as soon as the tube was seen to not freely enter the tracheal opening. For patient safety reasons, we wanted to avoid damage of the laryngeal structures. The fibrescope was not manipulated during the blind insertion attempt. This procedure could be called 'visualized blind technique' or 'tube first fibreoptic technique'. The first attempt success rate of blind tracheal intubation was our primary outcome measure. The TT was fixed to the fibrescope in a way that the tube's tip pointed upwards, and the black writing on the tube pointed to the back of the patient. 12 14 Thus, the TT followed the same course it would have followed with a completely blind intubation. At the same time, the fibrescope was not the leading part during tube advancement, but it provided continuous visualization to instantly recognize impossible intubation conditions and to prevent glottic structure damage.
In the case of failed first attempt of blind intubation, the fibrescope was advanced beyond the tip of the tube and was introduced into the trachea, and the TT was advanced over the fibrescope as done by Joo and Rose. 12 If fibreoptic intubation failed as well, the other SAD was used, but the success was not evaluated according to intention-to-treat analysis. If the alternative SAD failed or if Sp O 2 decreased to ,92% at any time, the SAD was abandoned and the airway secured according to the anaesthetist's decision. After intubation, the fibrescope was removed and the breathing circuit reconnected. Intubation time was measured from the time the breathing circuit was disconnected until the carbon dioxide curve appeared on the monitor.
During removal of the SAD, we carefully avoided accidental extubation. The ILMA TM stabilizer rod was used for both SADs, according to the ILMA TM user booklet. 18 Time to remove the SAD was measured from disconnection of the breathing system until reappearance of the carbon dioxide curve on the monitor. At this time, the study was finished and anaesthesia was maintained according to the anaesthetist.
Airway leak pressure
Airway leak pressure was measured by closing the circle system's expiratory valve at a fixed gas flow of 3 litres min 21 and noting the airway pressure (max. allowed 40 cm H 2 O) at which equilibrium was reached or audible air was leaking. 24 Air entering the stomach was detected by auscultation over the epigastrium. 21 
Adverse events
During the study period, from starting anaesthesia until discharge from the postoperative recovery unit, any adverse events were recorded. Adverse events were defined as suspicion of aspiration/regurgitation (gastric fluid in the ventilation tube or in the hypopharynx), hypoxia (Sp O 2 ,92%), hypotension (mean arterial pressure ,55 mm Hg), hypertension (mean arterial pressure +20% over pre-induction baseline), tachycardia and bradycardia (+20% of pre-induction value), bronchospasm, airway obstruction, coughing, dental, tongue, or lip trauma.
Evaluation of postoperative complaints
A structured interview with the patient was performed 24 h after the operation to obtain data about adverse effects. 25 In the case of ambulatory surgery, we called the patients by phone. The interviewer was not aware of any problems encountered during insertion or surgery and was blinded about randomization, and the performance of the SAD/TT. Items included sore throat, hoarseness, dysphagia, postoperative nausea and vomiting, rescue medication, pain, analgesics taken, and any unscheduled re-hospitalization.
Comparison with patients from accompanying study using alternative TT (i-gel TM with sILMA TM TT; sILMA TM with Magill PVC TT)
In order to check if the difference in blind intubation success rates was caused by the fact that we used two different TTs, we compared the data from the 80 patients with those from a similar group of patients described in an accompanying study. 26 These 40 patients were equally randomized to either SAD but were intubated through the i-gel TM with the sILMA TM tube and through the sILMA TM with the Magill PVC tube. Again, the primary outcome was the success rate of blind tracheal intubation.
Statistical analysis
On the basis of our experience with the i-gel TM , we expected a difference of at least 30% in first-attempt success rates (primary outcome measure) in favour of the sILMA TM , and we calculated our sample size according to these expectations. Our null hypothesis was that the difference of firstattempt blind intubation success rates between the two SADs would be ,30%. Our alternative hypothesis was that the difference of the success rates would be .30%. As firstattempt success rates for blind tracheal intubation for the ILMA TM are 80-87%, 11 
Results
Participants and patient characteristics
We screened 912 patients undergoing general anaesthesia in a time period of 8.5 months (total 265 days); 677 of them required tracheal intubation (624 were adults). Inclusion criteria were not fulfilled by 534 patients, leaving 90 patients with predictors of a difficult airway eligible for the study. Five patients did not give informed consent, and five others were not randomized because of changes in surgical procedure. Therefore, we investigated 80 patients (Fig. 3) . Patients' characteristics did not differ importantly ( Table 1) . We investigated more males than females (64% vs. 36%), but the ratio was equal in both SAD-groups. Furthermore, there were no differences in characteristics between the 80 patients and the 40 patients described in the accompanying study.
Mask ventilation was deemed to be easy in 60 cases, in the other 20 cases, either two-handed ventilation or a Guedel Airway was necessary.
Insertion of the SADs
There was no difference in the insertion success rates between i-gel TM and sILMA TM (Table 2 ). In one case of a failed i-gel TM insertion, the airway was rescued by oral intubation. One sILMA TM insertion failed because of inadequate ventilation without hypoxia. This patient's trachea was intubated by fibreoptic guidance through an i-gel TM . One i-gel TM had to be changed from size 4 to 5 in a male patient of 90 kg and 173 cm, although the size selection was according to the manufacturer's description. There were no differences in first-attempt success rates of SAD insertion, insertion time, airway leak pressure, and tidal volumes ( Table 2 ).
In the comparison group of 40 patients from the accompanying study, 26 ventilation after SAD insertion was successful in all i-gel TM patients, and in all but one sILMA TM patient.
Blind tracheal intubation
Blind intubation success rate was significantly higher for the sILMA TM group (69%) compared with the i-gel TM group (15%, P,0.001, Table 3 ). There was no difference in fibreoptic laryngeal view, epiglottic downfolding, and time necessary for intubation (Table 3) . Of the 12 patients who could not be blindly intubated in the sILMA TM group, 10 were intubated by fibreoptic guidance and in two patients, conventional laryngoscopy was necessary to finally secure the airway.
Of the 33 failed blind intubations in the i-gel TM group, 32 patients were intubated by fibreoptic-guided intubation and one by conventional intubation. In that one case, intubation through the i-gel TM was impossible because of an unusually small glottic opening, and the patient was intubated orally with a smaller size TT by the aid of a Frova TM catheter (Frova Intubating Introducers, Cook TM Medical Ireland Ltd, Limerick, Ireland). We found no significant difference for the successful fibreoptic intubation rate after a failed blind intubation attempt between both SADs.
Blind intubation in the comparison group of 40 patients 26 revealed a success rate of 21% for the sILMA TM tube through the i-gel TM and a success rate of 60% for the Magill PVC tube through the sILMA TM (P¼0.02). Because we found comparable patient characteristics, we performed a 2×2 analysis of the insertion success rate. That confirmed a large difference for the SADs (P¼0.001 and 0.002), but not for the tubes (P¼0.59 and 0.48, Table 4 ).
Removal of the SAD
All 78 inserted SADs were removed without complications using the ILMA TM exchange rod. There was no difference in removal time between both SADs [44 (20) s for the i-gel 
Haemodynamics, adverse events, and postoperative complaints
There were no differences in haemodynamic changes during insertion or intubation between the groups. One i-gel TM (3%) and two sILMAs TM (5%) were stained with blood after removal (P¼1.00).
In one patient, an i-gel TM failed and he desaturated below 90% before the intubation attempt. Conventional oral intubation secured the airway without any problem. Also, one patient with an sILMA TM in place desaturated briefly below 90% during fibreoptically guided intubation. There were no other adverse events.
There were no statistically significant differences in postoperative complaints between the groups; sore throat occurred in 25% (i-gel TM ) vs. 8% (sILMA TM ), P¼0.08.
Discussion
In this study, the success rate of blind intubation through the i-gel TM using a Magill PVC TT was significantly lower compared with the sILMA TM using the sILMA TM TT. This did not change if we used the other tube (i-gel TM with the sILMA TM tube, and sILMA TM with the Magill PVC tube). The airway outlet of the i-gel TM is large, and provides a good view of the vocal cords. Epiglottic downfolding is rare which favours a successful intubation. However, in relation to the laryngeal structures, the airway outlet of the i-gel TM seems to provide an unfavourable angle. When the TT exits the i-gel TM , it often gets caught in the arytenoid cartilage or other posterior structures of the larynx. In order to enter the trachea, fibrescope and tube often need to be pushed anterior. This might be improved by reshaping the airway outlet of the i-gel TM to optimize the angle. Compared with the success rate of the sILMA TM with the sILMA TM tube (69%), the i-gel TM with the Magill PVC tube had a success rate of only 15%, clearly favouring airway management using the sILMA TM with the sILMA TM tube. The success rate of blind intubation at the first attempt with the sILMA TM was only 69%. This is similar to a study published earlier comparing ILMA TM and sILMA TM , 27 but lower than expected from larger studies. 11 12 This may be a consequence of the selected patient population with predictors of difficult airway management. In addition, we performed the so-called blind intubation attempt without fibreoptic guidance, but under visual control with the scope. Therefore, whenever the TT experienced resistance from the posterior (or anterior) part of the larynx, the tube was not forced in any direction in order to prevent tissue damage. The success rate may have been higher without a visual control because one might tend to try to overcome the resistance. We only looked at first blind intubation success rate and did not allow airway manoeuvres known to facilitate blind intubation success. 18 The main purpose of the present study was to compare two different airway sets rather than determining the influence of different TTs. The success rate of blind intubation through the i-gel TM might be improved by using a different TT instead of the Magill PVC tube that was used in the current study. However, the results from our comparison group of 40 patients from the accompanying study 26 showed that the difference in success rates was rather attributed to the different SADs than to the different TTs (Table 4 ). The two different TTs did not cause the large difference in blind intubation success , n (%) 18 (45) 18 (45) TM,6 cm, n (%) 3 (08) 4 (10) No jaw protrusion, n (%) 4 (10) 4 (10) Sleep apnoea, n (%) 9 (23) 13 ( (7) rate, but we were unable to quantify their influence on our primary outcome measure. The sizes of the SADs were chosen according to the manufacturer's handbook; one i-gel TM had to be changed from size 4 to size 5 to obtain adequate seal. Two other i-gels TM had to be changed from size 4 to size 3. This reflects the ongoing discussion about SADs: size selection should also include patient characteristics such as height, 28 and perhaps even age and gender. 29 
Limitations of the study
We recognize some limitations to this study. First, we compared visualized blind intubation through SADs ('tube first fibreoptic technique'). We did not compare true blind intubation, where sometimes intubation is accomplished by overcoming resistance with light force. Instead, TT advancement was closely monitored in order to avoid damage of any laryngeal structures. The tip of the fibreoptic bronchoscope always remained proximal to the tip of the TT. There was no guidance or manipulation of the fibrescope, and the tube's path was the same as in a blind intubation attempt, mimicking clinical practice. Secondly, we included patients with predictors of difficult airway management. All predictors of difficult mask ventilation, difficult laryngoscopy, and difficult intubation qualified as inclusion criteria. Because of ethical considerations, we did not include patients with a history of difficult airway in this study, denying them the advantage of an awake fibreoptic intubation. Thirdly, we used the i-gel TM with a Magill PVC TT and compared this with the sILMA TM with its sILMA TM tube. The sILMA TM TT is specifically designed for blind intubation. By doing so, we did not only compare the SAD, but an airway set. We decided to use an everyday PVC TT for the i-gel TM and not the sILMA TM tube because in case of a cannot-ventilate -cannot-intubate situation, clinicians initially have to fall back on devices they have readily available in the operating theatre. That is, an SAD (e.g. the i-gel TM ) to re-establish ventilation which might be followed by intubation. Therefore, the clinician must know if a commonly used PVC tube is useful for blind airway rescue procedures. Fourthly, we compared the data from the 80 patients with data from a group of 40 patients described in another study. 26 These 40 patients were included in two studies, although different outcome measures were evaluated. The inclusion of these 40 patients is not a fully randomized 2×2 factorial analysis. We decided to include this group for comparison after analysis of the 80 patients described, in order to check if the difference in success rate was mainly attributable to the two different TTs. 30 The two patient populations showed no characteristic differences, they were collected with the same inclusion and exclusion criteria, and they were fully randomized. With a high probability, the SADs are largely responsible for the difference in success rates for blind intubation, and not the TTs. Finally, the study personnel were not all experts in the field of airway management; however, all 24 participating anaesthetists were experienced in the use of both SADs and fibreoptic intubation through SADs, and they were under supervision by one of the main study authors. Our results reflect true clinical performance of the devices in a daily clinical anaesthetic setting. Failures were evenly distributed among investigators. We also found no difference between the participating anaesthetists regarding intubation time.
In conclusion, we found that blind tracheal intubation through the i-gel TM using a PVC TT was substantially inferior compared with intubation through the sILMA TM using the sILMA TM TT in patients with predictors of difficult airway management under general anaesthesia. Therefore, we do not recommend blind intubation through the i-gel TM . The sILMA TM tube does not substantially improve blind intubation success with the i-gel TM as conduit. When blind intubation failed, fibreoptically guided intubation through the i-gel TM was highly successful.
